Author:
Sordillo Joanne E.,Kelly Rachel S.,Lutz Sharon M.,Lasky-Su Jessica,Wu Ann Chen
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference48 articles.
1. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017.
2. Martinez FD, Vercelli D. Asthma Lancet. 2013;382(9901):1360–72.
3. Billington CK, Penn RB, Hall IP. β2 Agonists. Handb Exp Pharmacol. 2017;237:23–40.
4. • Beasley R, Braithwaite I, Semprini A, Kearns C, Weatherall M, Pavord ID. Optimal asthma control: time for a new target. Am J Respir Crit Care Med. 2020;201(12):1480–7. This review discusses the current limitations of pharmacological treatment of adult asthma, and proposes the development of practical methods to identify treatable traits contributing to respiratory symptoms in asthma.
5. McGeachie MJ, Stahl EA, Himes BE, Pendergrass SA, Lima JJ, Irvin CG, et al. Polygenic heritability estimates in pharmacogenetics: focus on asthma and related phenotypes. Pharmacogenet Genomics. 2013;23(6):324–8.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献